WO2011139414A3 - Dexlansoprazole polymorphic forms - Google Patents

Dexlansoprazole polymorphic forms Download PDF

Info

Publication number
WO2011139414A3
WO2011139414A3 PCT/US2011/028484 US2011028484W WO2011139414A3 WO 2011139414 A3 WO2011139414 A3 WO 2011139414A3 US 2011028484 W US2011028484 W US 2011028484W WO 2011139414 A3 WO2011139414 A3 WO 2011139414A3
Authority
WO
WIPO (PCT)
Prior art keywords
dexlansoprazole
polymorphic forms
forms
polymorphic
useful
Prior art date
Application number
PCT/US2011/028484
Other languages
French (fr)
Other versions
WO2011139414A2 (en
Inventor
Srividya Ramakrishnan
Vamsee Krishna Muppidi
Subba Reddy Peddireddy
Vamsi Krishna Mudapaka
Rashmi Agrawal
Original Assignee
Dr. Reddy's Laboratories Ltd.
Dr. Reddy's Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc. filed Critical Dr. Reddy's Laboratories Ltd.
Publication of WO2011139414A2 publication Critical patent/WO2011139414A2/en
Publication of WO2011139414A3 publication Critical patent/WO2011139414A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole

Abstract

The application relates to polymorphic forms of dexlansoprazole that are useful in making pharmaceutically acceptable dosage forms, and processes for their preparation. The structure of dexlansoprazole (1) is shown below..
PCT/US2011/028484 2010-04-27 2011-03-15 Dexlansoprazole polymorphic forms WO2011139414A2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
IN1167CH2010 2010-04-27
IN1167/CHE/2010 2010-04-27
US34570710P 2010-05-18 2010-05-18
US61/345,707 2010-05-18
US36079010P 2010-07-01 2010-07-01
US61/360,790 2010-07-01

Publications (2)

Publication Number Publication Date
WO2011139414A2 WO2011139414A2 (en) 2011-11-10
WO2011139414A3 true WO2011139414A3 (en) 2011-12-29

Family

ID=44904293

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/028484 WO2011139414A2 (en) 2010-04-27 2011-03-15 Dexlansoprazole polymorphic forms

Country Status (1)

Country Link
WO (1) WO2011139414A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013140120A1 (en) 2012-03-22 2013-09-26 Cipla Limited Glycerol solvate forms of (r) - 2 - [ [ [3 -methyl -4 (2,2, 2 - trifluoroethoxy) pyridin- 2 - yl] methyl] sulphinyl] - 1h - ben zimidazole
WO2013179194A1 (en) * 2012-05-31 2013-12-05 Ranbaxy Laboratories Limited Process for the preparation of crystalline dexlansoprazole

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009088857A1 (en) * 2007-12-31 2009-07-16 Takeda Pharmaceutical Company Limited Crystalline solvated forms of (r) -2- [ [ [3-methyl-4- (2, 2, 2-trifluoroethoxy) -2-pyridinyl] methyl] sulfinyl] -1h-benz imidazole
WO2009117489A1 (en) * 2008-03-18 2009-09-24 Dr. Reddy's Laboratories Ltd. Dexlansoprazole process and polymorphs
WO2010039885A2 (en) * 2008-09-30 2010-04-08 Teva Pharmaceutical Industries Ltd. Crystalline forms of dexlansoprazole

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009088857A1 (en) * 2007-12-31 2009-07-16 Takeda Pharmaceutical Company Limited Crystalline solvated forms of (r) -2- [ [ [3-methyl-4- (2, 2, 2-trifluoroethoxy) -2-pyridinyl] methyl] sulfinyl] -1h-benz imidazole
WO2009117489A1 (en) * 2008-03-18 2009-09-24 Dr. Reddy's Laboratories Ltd. Dexlansoprazole process and polymorphs
WO2010039885A2 (en) * 2008-09-30 2010-04-08 Teva Pharmaceutical Industries Ltd. Crystalline forms of dexlansoprazole

Also Published As

Publication number Publication date
WO2011139414A2 (en) 2011-11-10

Similar Documents

Publication Publication Date Title
WO2012075383A3 (en) Bromodomain inhibitors and uses thereof
WO2012174487A8 (en) Bromodomain inhibitors and uses thereof
WO2012151512A3 (en) Bromodomain inhibitors and uses thereof
WO2013184876A8 (en) Benzo [c] isoxazoloazepine bromodomain inhibitors and uses thereof
GB0906579D0 (en) Pharmaceuticals, compositions and methods of making and using the same
WO2010151541A8 (en) Polymorphic form d of bazedoxifene acetate and methods of preparing same
WO2012021715A3 (en) Stable formulations of linaclotide
WO2010092090A3 (en) Novel salts of sitagliptin
WO2012125438A8 (en) Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
WO2014045162A8 (en) ALKYL-SUBSTITUTED HEXAHYDROPYRANO[3,4-d] [1,3]THIAZIN-2-AMINE COMPOUNDS
SG10201804817TA (en) Delayed release compositions of linaclotide
EP2320740A4 (en) Pharmaceutical compositions and methods for producing low impurity concentrations of the same
WO2011017502A3 (en) Linaclotide-containing formulations for oral administration
WO2011079193A3 (en) Preparation of bendamustine and its salts
WO2011009938A3 (en) Stambomycin and derivatives, their production and their use as drugs
WO2012125981A3 (en) Raf kinase inhibitors
WO2010049449A3 (en) Novel salts of sunitinib
WO2012015999A3 (en) Process for the preparation of imatinib mesylate
MX2012001691A (en) Orally disintegrating compositions of linaclotide.
WO2010065586A3 (en) Preparation of capecitabine
MX2015000179A (en) Itraconazole compositions and dosage forms, and methods of using the same.
WO2010148314A3 (en) Preparation of esomeprazole and its pharmaceutically acceptable salts
WO2011023954A3 (en) Polymorphic forms of manidipine
WO2012018791A3 (en) Preparation of prasugrel hydrochloride
HUP1000565A2 (en) Process for the preparation of pharmaceutically active compound and intermediers

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11777739

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11777739

Country of ref document: EP

Kind code of ref document: A2